Absci (ABSI) Equity Average (2021 - 2026)
Absci's (ABSI) quarterly Equity Average came in at $180.7 million in Q1 2026, down 4.37% year-on-year from $189.0 million in Q1 2025, and down 9.6% quarter-over-quarter from $199.9 million in Q4 2025.
Absci (ABSI) Equity Average (2021 - 2026) Analysis & Trends
Absci has disclosed Equity Average across 6 years of filings, most recently posting $180.7 million for Q1 2026.
- Equity Average for Q1 2026 came in at $180.7 million, down 4.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $180.7 million (down 4.37% YoY), and the FY2025 annual result was $184.3 million, up 3.74% from the prior year.
- Equity Average came in at $180.7 million for Q1 2026 at Absci, down from $199.9 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $353.3 million in Q1 2022 to a low of $180.7 million in Q1 2026.
- The 5-year median for Equity Average is $208.1 million (2024), against an average of $232.3 million.
- Across the five-year window, Equity Average soared 475.99% in 2022 and slumped 34.33% in 2023, its largest moves.
- Absci's Equity Average stood at $283.7 million in 2022, then plunged by 34.33% to $186.3 million in 2023, then increased by 2.11% to $190.2 million in 2024, then advanced by 5.08% to $199.9 million in 2025, then fell by 9.6% to $180.7 million in 2026.
- The last three Equity Average figures came in at $180.7 million (Q1 2026), $199.9 million (Q4 2025), and $191.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 180.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 180.71 Mn |
| Dec 31, 2025 | 199.89 Mn |
| Sep 30, 2025 | 191.86 Mn |
| Jun 30, 2025 | 186.08 Mn |
| Mar 31, 2025 | 188.96 Mn |
| Dec 31, 2024 | 190.23 Mn |
| Sep 30, 2024 | 211.41 Mn |
| Jun 30, 2024 | 230.80 Mn |
| Mar 31, 2024 | 208.14 Mn |
| Dec 31, 2023 | 186.30 Mn |
| Sep 30, 2023 | 205.91 Mn |
| Jun 30, 2023 | 234.68 Mn |
| Mar 31, 2023 | 264.19 Mn |
| Dec 31, 2022 | 283.68 Mn |
| Sep 30, 2022 | 304.57 Mn |
| Jun 30, 2022 | 328.34 Mn |
| Mar 31, 2022 | 353.30 Mn |
| Dec 31, 2021 | 377.06 Mn |
| Sep 30, 2021 | 131.88 Mn |
| Jun 30, 2021 | -111.38 Mn |